-
Breast cancer risk SNPs converge on estrogen receptor binding sites commonly shared between breast tumors to locally alter estrogen signalling output
Study
EGAS50000000008
-
EARLY DIAgnosis of PAncreatic Cancer (EARLY DIAPAC) study
Study
EGAS50000000611
-
Genetics and transcriptomics of human acute erythroid leukemia
Study
EGAS00001004203
-
Association of DNA-methylation profiles with immune responses in breast cancer patients
Study
EGAS00001004211
-
Nurminen et al ("GP2Men") Study Primary and Metastatic Prostate Cancer Whole Genome Sequence Data
Study
EGAS50000000005
-
Whole exome sequencing of pediatric soft tissue sarcoma PDX models
Study
EGAS50000000048
-
The genomic basis of childhood T-lineage acute lymphoblastic leukemia
Study
EGAS50000000016
-
Efficacy of two different FGFR-inhibitors in a patient with extrahepatic cholangiocarcinoma harboring an FGFR2 mutation
Study
EGAS50000000015
-
Identification and targeting of extremely high-risk gamma delta T-ALL in children
Study
EGAS50000000018
-
: Centromeric cohesion failure invokes a conserved choreography of chromosomal mis-segregations in pancreatic neuroendocrine tumours
Study
EGAS00001004239
-
Aberrant EZHIP Expression Drives Tumorigenesis in Osteosarcoma
Study
EGAS00001007531
-
Genetic characterization of a Unique Neuroendocrine Transdifferentiation Prostate Circulating Tumor Cell - Derived eXplant (CDX) Model
Study
EGAS00001004272
-
Multidimensional Proteomics analysis of intractable cancers with prospective observational cohort for precision medicine
Study
EGAS50000000592
-
Single-Cell RNA-seq of Primary High Grade Serous Carcinoma
Study
EGAS50000000068
-
Single-cell profiling reveals mechanisms of response to anti-PD-L1 versus anti-PD-L1 combined with anti-CTLA4 in head and neck squamous cell carcinoma
Study
EGAS50000000037
-
Arcagen – thoracic malignancies
Study
EGAS50000000123
-
Converging and evolving immuno-genomic routes towards immune escape in breast cancer
Study
EGAS00001004956
-
CIRCLE-seq of PDAC PDO
Study
EGAS50000000194
-
Origination of Ovarian Cancer is Dependent on Specific Aneuploidy Landscape
Study
EGAS00001007220
-
Age-dependent association of clonal hematopoiesis with COVID-19 mortality in patients over 60 years
Study
EGAS50000000001
-
Bone metastatic biopsies of breast cancer patients progressing on endocrine therapies.
Study
EGAS00001004268
-
Long-read-transcriptome-sequencing of CLL and MDS patients uncovers common molecular effects of SF3B1 mutations
Study
EGAS50000000053
-
Recording physiological history of cells with chemical labeling.
Study
EGAS50000000056
-
Multimodal epigenetic sequencing analysis for colon cancer
Study
EGAS50000000052
-
Identification of germline variants in Medullary thyroid carcinoma (MTC) by whole- exome sequencing
Study
EGAS50000000061
-
Genomic determinants of response and resistance to inotuzumab in B-ALL
Study
EGAS50000000067
-
Genomic Profiling of Pediatric Tumors by Cell Free DNA Sequencing
Study
EGAS50000000072
-
Colon cancer targeted sequencing study contaning WBCs, primary tumor tissue and plasma samples
Study
EGAS50000000059
-
Targeted sequencing (paired) of HR genes in primary and metastatic patient-derived xenografts (PDXs) of colorectal cancer (CRC)
Study
EGAS50000000075
-
A clinically and genomically annotated Early onset colorectal cancer and late onset colorectal cancer
Study
EGAS50000000544
-
Identifying mutations in patient-derived melanoma DCC lines
Study
EGAS50000001225
-
Eribulin efficacy in platinum-resistant and refractory high-grade serous ovarian cancer patient-derived xenograft models
Study
EGAS50000000152
-
Whole genome bisulfite sequencing of prostate cancer samples upon oral pimonidazole administration
Study
EGAS50000000069
-
MediMer: A versatile do-it-yourself peptide-receptive MHC class I multimer platform for tumor neoantigen-specific T cell detection
Study
EGAS50000000065
-
RNA-Sequencing of cervical cancers
Study
EGAS50000000087
-
Metabolic requirements of the metastasis-initiating tumour cell population using oral squamous cell carcinoma (OSCC) as a model system
Study
EGAS00001004765
-
Cerebrospinal fluid cfDNA sequencing for classification of central nervous system glioma
Study
EGAS50000000060
-
AVENIO Expanded ctDNA panel sequence alignments (BAMs) from plasma DNA of lung cancer patients from the OSCILLATE trial
Study
EGAS50000000103
-
Immunomodulatory effects and improved outcomes with cisplatin- vs carboplatin-based chemotherapy plus atezolizumab in urothelial cancer
Study
EGAS50000000104
-
Transcriptomic profiles of early and late passage metastatic colorectal cancer (mCRC) tumoroids
Study
EGAS50000000108
-
Clones derived from early passage tumoroids of colorectal cancer
Study
EGAS50000000107
-
Altered enhancer-promoter interaction leads to MNX1 expression in pediatric acute myeloid leukemia with t(7;12)(q36;p13)
Study
EGAS50000000130
-
Efficacy and safety of entrectinib in patients with ROS1-positive advanced/metastatic non-small cell lung cancer (NSCLC) from the Blood First Assay Screening Trial (BFAST)
Study
EGAS50000000105
-
Low-coverage whole-sequencing of metastasised colorectal cancer samples treated with bevazicumab
Study
EGAS50000000131
-
Multiregion Whole-Exome Sequencing Uncovers the Genetic Evolution and Mutational Heterogeneity of Early-Stage Metastatic Melanoma.
Study
EGAS00001004320
-
Cancer-associated fibroblasts promote drug resistance in ALK-driven lung adenocarcinoma cells by upregulating lipid biosynthesis
Study
EGAS50000000135
-
Activating AKT1 and PIK3CA mutations in metastatic castration-resistant prostate cancer
Study
EGAS00001004328
-
SCANDARE MACARON
Study
EGAS50000000145
-
Small‑scale mutations are infrequent as mechanisms of resistance in post‑PARP inhibitor tumour samples in high grade serous ovarian cancer
Study
EGAS50000000146
-
Whole exome sequencing of bladder tumors
Study
EGAS50000001248